搜索优化
English
网页
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
4 小时
Only an act of Congress can stop pharmacy monopolies, Sen. Lankford says
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
Becker's Hospital Review
21 小时
Big 3 PBM formularies favor private-label biosimilars
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
1 天
on MSN
Local pharmacy to close after 68 years — here’s why
After almost seven decades of providing medication and more to the people of San Angelo, Medical Arts Pharmacy is shutting ...
Modern Healthcare
9 天
Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
6 天
on MSN
Columbus joins national fight accusing drug manufacturers of inflating insulin prices
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
8 天
on MSN
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Healthcare Dive
8 天
FTC releases second report slamming pharmacy benefit managers
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
8 天
on MSN
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
News9
14 小时
OKC sues PBMs and insulin manufacturers over price gouging
City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...
8 天
on MSN
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
1 天
Evercore ISI Sticks to Its Buy Rating for CVS Health (CVS)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈